Pfizer Invest Information

Valneva SE to Engage in Investor Conferences Highlighting June 2024 Agenda Jun 4, 2024

Valneva Showcases Innovative Chikungunya Vaccine at World Vaccine Congress Mar 21, 2024

EMA Validates Marketing Application for Tisotumab Vedotin, A Potential Treatment for Recurrent or Metastatic Cervical Cancer Feb 3, 2024

LITFULO™ Wins Health Canada Nod as Novel Alopecia Areata Treatment Dec 5, 2023